journal
https://read.qxmd.com/read/38204440/benchmark-for-establishment-of-organoids-from-gastrointestinal-epithelium-and-cancer-based-on-available-consumables-and-reagents
#21
JOURNAL ARTICLE
Ruixin Yang, Zhen Xiang, Ranlin Yan, Wingyan Kwan, Lu Zang, Zhenggang Zhu, Yao Qi, Yanping Xu, Xiaoyan Zhang, Hengjun Gao, Yingyan Yu
Gastrointestinal cancers are a public health problem that threatens the lives of human being. A good experimental model is a powerful tool to promote the uncovering pathogenesis and establish novel treatment methods. High-quality biomedical research requires experimental models to recapitulate the physiological and pathological states of their parental tissues as much as possible. Organoids are such experimental models. Organoids refer to small organ-like cellular clusters formed by the expansion and passaging of living tissues in 3D culture medium in vitro ...
December 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38204439/unveiling-clinical-significance-and-tumor-immune-landscape-of-cxcl12-in-bladder-cancer-insights-from-multiple-omics-analysis
#22
JOURNAL ARTICLE
Zhouting Tuo, Dechao Feng, Zhiwei Jiang, Liangkuan Bi, Chao Yang, Qi Wang
OBJECTIVE: The interplay between chemokine C-X-C motif ligand 12 (CXCL12) and its specific receptors is known to trigger various signaling pathways, contributing to tumor proliferation and metastasis. Consequently, targeting this signaling axis has emerged as a potential strategy in cancer therapy. However, the precise role of CXCL12 in clinical therapy, especially in immunotherapy for bladder cancer (BCa), remains poorly elucidated. METHODS: We gathered multiple omics data from public databases to unveil the clinical relevance and tumor immune landscape associated with CXCL12 in BCa patients...
December 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37969964/genetic-susceptibility-loci-of-lung-cancer-are-associated-with-malignant-risk-of-pulmonary-nodules-and-improve-malignancy-diagnosis-based-on-cea-levels
#23
JOURNAL ARTICLE
Zhi Li, Liming Lu, Yibin Deng, Amei Zhuo, Fengling Hu, Wanwen Sun, Guitian Huang, Linyuan Liu, Boqi Rao, Jiachun Lu, Lei Yang
OBJECTIVE: The heightened prevalence of pulmonary nodules (PN) has escalated its significance as a public health concern. While the precise identification of high-risk PN carriers for malignancy remains an ongoing challenge, genetic variants hold potentials as determinants of disease susceptibility that can aid in diagnosis. Yet, current understanding of the genetic loci associated with malignant PN (MPN) risk is limited. METHODS: A frequency-matched case-control study was performed, comprising 247 MPN cases and 412 benign NP (BNP) controls...
October 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37969963/comments-on-national-health-commission-guidelines-for-diagnosis-and-treatment-of-colorectal-cancer-2023-in-china-english-version
#24
JOURNAL ARTICLE
Yong Yang, Zhaoya Gao, Jin Gu
No abstract text is available yet for this article.
October 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37969962/opennau-an-open-source-platform-for-normalizing-analyzing-and-visualizing-cancer-untargeted-metabolomics-data
#25
JOURNAL ARTICLE
Qingrong Sun, Qingqing Xu, Majie Wang, Yongcheng Wang, Dandan Zhang, Maode Lai
OBJECTIVE: As an important part of metabolomics analysis, untargeted metabolomics has become a powerful tool in the study of tumor mechanisms and the discovery of metabolic markers with high-throughput spectrometric data which also poses great challenges to data analysis, from the extraction of raw data to the identification of differential metabolites. To date, a large number of analytical tools and processes have been developed and constructed to serve untargeted metabolomics research...
October 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37969961/update-of-latest-data-for-combined-therapy-for-esophageal-cancer-using-radiotherapy-and-immunotherapy-a-focus-on-efficacy-safety-and-biomarkers
#26
JOURNAL ARTICLE
Shuping Cheng, Butuo Li, Jinming Yu, Linlin Wang
Esophageal cancer usually has a poor prognosis. Given the significant breakthrough with tumor immunotherapy, an increasing number of clinical studies have demonstrated that the combination of radiotherapy and immune checkpoint inhibitors (ICIs) may have a synergistic effect and good outcome in esophageal cancer. Clinical studies of immunoradiotherapy (iRT) for esophageal cancer have proliferated enormously from 2021 to the present. However, a summary of the efficacy and toxicity of combined therapy to guide esophageal cancer treatment in clinical practice is lacking...
October 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37969960/genetic-abnormalities-assist-in-pathological-diagnosis-and-ebv-positive-cell-density-impact-survival-in-chinese-angioimmunoblastic-t-cell-lymphoma-patients
#27
JOURNAL ARTICLE
Yunfei Shi, Haojie Wang, Yanfei Liu, Mengping Long, Ning Ding, Lan Mi, Yumei Lai, Lixin Zhou, Xinting Diao, Xianghong Li, Weiping Liu, Jun Zhu
OBJECTIVE: To explore the application of genetic abnormalities in the diagnosis of angioimmunoblastic T-cell lymphoma (AITL) and the reliable pathological prognostic factors. METHODS: This study included 53 AITL cases, which were reviewed for morphological patterns, immunophenotypes, presence of Hodgkin and Reed-Sternberg (HRS)-like cells, and co-occurrence of B cell proliferation. The Epstein-Barr virus (EBV)-positive cells in tissues were counted, and cases were classified into "EBV encoded RNA (EBER) high-density" group if >50/HPF...
October 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37969959/mrd-directed-and-risk-adapted-individualized-stratified-treatment-of-aml
#28
JOURNAL ARTICLE
Yijing Zhao, Hanfei Guo, Yingjun Chang
Measurable residual disease (MRD) has been widely recognized as a biomarker for deeply evaluating complete remission (CR), predicting relapse, guiding pre-emptive interventions, and serving as an endpoint surrogate for drug testing. However, despite the emergence of new technologies, there remains a lack of comprehensive understanding regarding the proper techniques, sample materials, and optimal time points for MRD assessment. In this review, we summarized the MRD methods, sample sources, and evaluation frequency according to the risk category of the European Leukemia Net (ELN) 2022...
October 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37969958/baseline-radiologic-features-as-predictors-of-efficacy-in-patients-with-pancreatic-neuroendocrine-tumors-with-liver-metastases-receiving-surufatinib
#29
JOURNAL ARTICLE
Jianwei Zhang, Haibin Zhu, Lin Shen, Jie Li, Xiaoyan Zhang, Chunmei Bai, Zhiwei Zhou, Xianrui Yu, Zhiping Li, Enxiao Li, Xianglin Yuan, Wenhui Lou, Yihebali Chi, Nong Xu, Yongmei Yin, Yuxian Bai, Tao Zhang, Dianrong Xiu, Jia Chen, Shukui Qin, Xiuwen Wang, Yujie Yang, Haoyun Shi, Xian Luo, Songhua Fan, Weiguo Su, Ming Lu, Jianming Xu
OBJECTIVE: Currently, pre-treatment prediction of patients with pancreatic neuroendocrine tumors with liver metastases (PNELM) receiving surufatinib treatment was unsatisfying. Our objective was to examine the association between radiological characteristics and efficacy/prognosis. METHODS: We enrolled patients with liver metastases in the phase III, SANET-p trial (NCT02589821) and obtained contrast-enhanced computed tomography (CECT) images. Qualitative and quantitative parameters including hepatic tumor margins, lesion volumes, enhancement pattern, localization types, and enhancement ratios were evaluated...
October 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37969957/epidemiology-of-pancreatic-cancer-new-version-new-vision
#30
JOURNAL ARTICLE
Wenhao Luo, Jun Wang, Hao Chen, Liyuan Ye, Jiangdong Qiu, Yueze Liu, Ruobing Wang, Guihu Weng, Tao Liu, Dan Su, Jinxin Tao, Chen Ding, Lei You, Taiping Zhang
Pancreatic cancer (PC) is a devastating malignancy with an extremely high mortality rate and poses significant challenges to healthcare systems worldwide. The prevalence of PC risk factors spiked over the years, leading to a global increase in PC incidence rates. The contribution of different risk factors, however, varied from region to region due to genetic predisposition, environmental, social, and political factors underlying disease prevalence in addition to public health strategies. This comprehensive review aims to provide a thorough analysis of the epidemiology of PC, discussing its incidence, risk factors, screening strategies and socioeconomic burden...
October 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37969956/advances-breakthroughs-and-challenges-in-gastric-cancer-surgery
#31
JOURNAL ARTICLE
Hayun Kim, Sungsoo Park
Gastric cancer (GC) remains a substantial health burden worldwide, ranking fifth in incidence and third in mortality among all cancer types. Surgeons have persistently attempted to address this growing burden through surgical management of GC encompassing various aspects of surgery, including advances in surgical techniques and tools for minimally invasive surgery, novel technology for real-time image-guided surgery, and function-preserving and oncometabolic surgeries, aimed at improving patients' quality of life...
October 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37969955/a-novel-multimodal-prediction-model-based-on-dna-methylation-biomarkers-and-low-dose-computed-tomography-images-for-identifying-early-stage-lung-cancer
#32
JOURNAL ARTICLE
Jing Zhang, Haohua Yao, Chunliu Lai, Xue Sun, Xiujuan Yang, Shurong Li, Yubiao Guo, Junhang Luo, Zhihua Wen, Kejing Tang
OBJECTIVE: DNA methylation alterations are early events in carcinogenesis and immune signalling in lung cancer. This study aimed to develop a model based on short stature homeobox 2 gene ( SHOX2 )/prostaglandin E receptor 4 gene ( PTGER4 ) DNA methylation in plasma, appearance subtype of pulmonary nodules (PNs) and low-dose computed tomography (LDCT) images to distinguish early-stage lung cancers. METHODS: We developed a multimodal prediction model with a training set of 257 individuals...
October 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37969954/inspired-by-novel-radiopharmaceuticals-rush-hour-of-nuclear-medicine
#33
JOURNAL ARTICLE
Yang Liu, Ya-Nan Ren, Yan Cui, Song Liu, Zhi Yang, Hua Zhu, Nan Li
Nuclear medicine plays an irreplaceable role in the diagnosis and treatment of tumors. Radiopharmaceuticals are important components of nuclear medicine. Among the radiopharmaceuticals approved by the Food and Drug Administration (FDA), radio-tracers targeting prostate-specific membrane antigen (PSMA) and somatostatin receptor (SSTR) have held essential positions in the diagnosis and treatment of prostate cancers and neuroendocrine neoplasms, respectively. In recent years, FDA-approved serials of immune-therapy and targeted therapy drugs targeting programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1), human epidermal growth factor receptor 2 (HER2), and nectin cell adhesion molecule 4 (Nectin 4)...
October 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37691897/impact-of-preoperative-therapy-on-surgical-outcomes-of-laparoscopic-total-gastrectomy-for-gastric-gastroesophageal-junction-cancer
#34
JOURNAL ARTICLE
Yuehong Chen, Zhijing Yang, Mingli Zhao, Chuanjin Xu, Yuxuan Zhu, Huimin Zhang, Huilin Huang, Yanmei Peng, Yanfeng Hu, Tian Lin, Tao Chen, Hao Chen, Liying Zhao, Hao Liu, Guoxin Li, Jiang Yu, Xinhua Chen
OBJECTIVE: As laparoscopic surgery is widely applied for primarily treated gastric cancer (GC)/gastroesophageal junction cancer (GEJC) and gains many advantages, the feasibility of laparoscopic total gastrectomy (LTG) for GC/GEJC patients who have received preoperative therapy (PT) has come to the fore. This study aims to analyze the safety and feasibility of LTG after PT for GC/GEJC patients. METHODS: We retrospectively analyzed the data of 511 patients with GC/GEJC undergoing LTG, of which 405 received LTG (LTG group) and 106 received PT+LTG (PT-LTG group) at Nanfang Hospital between June 2018 and September 2022...
August 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37691896/research-progress-of-minimally-invasive-surgery-for-gastric-cancer
#35
JOURNAL ARTICLE
Hao Su, Zhaode Bu
Since the first laparoscopic radical surgery for early gastric cancer 30 years ago, there has been a gradual shift from "open" to "minimally invasive" surgery for gastric cancer. This transition is due to advancements in refined anatomy, enlarged field of view, faster recovery, and comparable oncological outcomes. Several high-quality clinical studies have demonstrated the safety and effectiveness of laparoscopy in the treatment of both early and locally advanced gastric cancer. The role of perioperative chemotherapy in managing locally advanced gastric cancer has been widely recognized, and there have been continuous breakthroughs in the exploration of targeted therapy and immunotherapy for perioperative treatment...
August 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37691895/detection-and-classification-of-breast-lesions-using-multiple-information-on-contrast-enhanced-mammography-by-a-multiprocess-deep-learning-system-a-multicenter-study
#36
JOURNAL ARTICLE
Yuqian Chen, Zhen Hua, Fan Lin, Tiantian Zheng, Heng Zhou, Shijie Zhang, Jing Gao, Zhongyi Wang, Huafei Shao, Wenjuan Li, Fengjie Liu, Simin Wang, Yan Zhang, Feng Zhao, Hao Liu, Haizhu Xie, Heng Ma, Haicheng Zhang, Ning Mao
OBJECTIVE: Accurate detection and classification of breast lesions in early stage is crucial to timely formulate effective treatments for patients. We aim to develop a fully automatic system to detect and classify breast lesions using multiple contrast-enhanced mammography (CEM) images. METHODS: In this study, a total of 1,903 females who underwent CEM examination from three hospitals were enrolled as the training set, internal testing set, pooled external testing set and prospective testing set...
August 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37691894/application-of-single-cell-rna-sequencing-in-head-and-neck-squamous-cell-carcinoma
#37
JOURNAL ARTICLE
Zhaohong An, Wan Liu, Wenbin Li, Minghui Wei, Changming An
Single-cell RNA sequencing has been broadly applied to head and neck squamous cell carcinoma (HNSCC) for characterizing the heterogeneity and genomic mutations of HNSCC benefiting from the advantage of single-cell resolution. We summarized most of the current studies and aimed to explore their research methods and ideas, as well as how to transform them into clinical applications. Through single-cell RNA sequencing, we found the differences in tumor cells' expression programs and differentiation tracks. The studies of immune microenvironment allowed us to distinguish immune cell subpopulations, the extensive expression of immune checkpoints, and the complex crosstalk network between immune cells and non-immune cells...
August 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37691893/efficacy-and-safety-of-anlotinib-as-an-adjuvant-therapy-in-hepatocellular-carcinoma-patients-with-a-high-risk-of-postoperative-recurrence
#38
JOURNAL ARTICLE
Jianguo Wang, Xiaonan Xiang, Zhixiong Shi, Hui Zhang, Quanbao Zhang, Zhikun Liu, Guangjie Zhao, Chuanxing Wu, Qiang Wei, Lin Zhong, Zhengxin Wang, Guoyue Lv, Shusen Zheng, Xiao Xu
OBJECTIVE: Hepatocellular carcinoma (HCC) has a high rate of postoperative recurrence and lacks an effective treatment to prevent recurrence. This study aims to investigate the efficacy and safety of anlotinib in postoperative adjuvant therapy for HCC patients with high-risk recurrence factors. METHODS: For this multicenter, retrospective study, we recruited 63 HCC patients who received either anlotinib (n=27) or transcatheter arterial chemoembolization (TACE) (n=36) from six research centers in China between March 2019 and October 2020...
August 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37691892/focal-ablation-therapy-presents-promising-results-for-selectively-localized-prostate-cancer-patients
#39
JOURNAL ARTICLE
Dechao Feng, Dengxiong Li, Yuhan Xiao, Ruicheng Wu, Jie Wang, Chi Zhang
Due to its lower risk of consequences when compared to a radical approach, focal treatment is a viable and minimally invasive option for treating specific localized prostate cancer. Although several recent good non-randomized trials have suggested that focused therapy may be an alternative choice for some patients, additional high-quality evidence is needed before it can be made widely available as a conventional treatment. As a result, we have summarized the most recent findings from the 38th Annual European Association of Urology Congress, one of the most renowned annual conferences in the area of urology, regarding focal ablation therapy for patients with localized prostate cancer...
August 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/37691891/striatins-and-stripak-complex-partners-in-clinical-outcomes-of-patients-with-breast-cancer-and-responses-to-drug-treatment
#40
JOURNAL ARTICLE
Amber Xinyu Li, Jimmy Jianyuan Zeng, Tracey A Martin, Lin Ye, Fiona Ruge, Andrew J Sanders, Elyas Khan, Q Ping Dou, Eleri Davies, Wen G Jiang
OBJECTIVE: Striatins (STRNs) family, which contains three multi-domain scaffolding proteins, are cornerstones of the striatins interacting phosphatase and kinase (STRIPAK) complex. Although the role of the STRIPAK complex in cancer has become recognized in recent years, its clinical significance in breast cancer has not been fully established. METHODS: Using a freshly frozen breast cancer tissue cohort containing both cancerous and adjacent normal mammary tissues, we quantitatively evaluated the transcript-level expression of all members within the STRIPAK complex along with some key interacting and regulatory proteins of STRNs...
August 30, 2023: Chinese Journal of Cancer Research
journal
journal
31474
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.